- provides a secure and clear setting for compounding of dangerous drug preparations in compliance with USP and conditions. It is well suited for do the job involving harmful products, antineoplastic, or cytotoxic compounding programs. Manufacturers aiming to carry out these approaches will have to supply sturdy validation data to demonstrat